Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000950170-25-001210

Options or other derivatives

  • Director acquired 2,785 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ferrante Karen Jean · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-01-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +2,785 2,785 D
Loading xslF345X05/ownership.xml…